GSA CAPITAL PARTNERS LLP - ADVERUM BIOTECHNOLOGIES INC ownership

ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 162 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q3 2020. The put-call ratio across all filers is 0.63 and the average weighting 0.4%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of ADVERUM BIOTECHNOLOGIES INC
ValueSharesWeighting
Q2 2023$195
-69.1%
122,676
-86.1%
0.02%
-69.4%
Q1 2023$631
+31.2%
879,684
+5.9%
0.06%
+3.3%
Q4 2022$481
-99.4%
830,829
+950.7%
0.06%
+500.0%
Q3 2022$75,000
-85.5%
79,076
-80.0%
0.01%
-85.7%
Q1 2022$518,000
-43.6%
395,585
-24.3%
0.07%
-39.1%
Q4 2021$919,000
+665.8%
522,284
+4378.9%
0.12%
+475.0%
Q3 2020$120,000
-36.2%
11,661
-28.4%
0.02%
-9.1%
Q4 2019$188,000
+108.9%
16,278
+10.0%
0.02%
+340.0%
Q3 2018$90,00014,8000.01%
Other shareholders
ADVERUM BIOTECHNOLOGIES INC shareholders Q3 2020
NameSharesValueWeighting ↓
Versant Venture Management, LLC 5,068,233$17,739,0005.88%
Sonic Fund II, L.P. 6,552,068$22,932,0001.69%
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) 480,000$1,680,0000.88%
Avoro Capital Advisors LLC 6,950,000$24,325,0000.42%
RTW INVESTMENTS, LP 7,357,917$25,753,0000.39%
K2 PRINCIPAL FUND, L.P. 898,307$3,144,0000.26%
Artal Group S.A. 3,000,000$10,500,0000.21%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,827,000$9,895,0000.18%
WS MANAGEMENT LLLP 307,442$1,076,0000.11%
ALGERT GLOBAL LLC 82,145$288,0000.10%
View complete list of ADVERUM BIOTECHNOLOGIES INC shareholders